Dave Muoio

August 28, 2018
Pivotal trial data that led to April’s de novo clearance of the first AI-based diagnostic system to not require clinician interpretation is now available to the public. Published today in npj Digital Medicine, this 900-patient investigation showed that the IDx-Dr system for autonomous detection of diabetic retinopathy “robustly exceeded the pre-specified primary endpoint goals” and is able to...
August 28, 2018
Last week Renovia, maker of an FDA-cleared, app-based system for pelvic floor disorder management and therapy, announced the closure of a $32.3 million Series B equity round and an additional $10 million of debt financing. The round was led by Perceptive Advisors and Ascension Ventures, with additional participation from Longwood Fund, Inova Strategic Investments, Cormorant Asset Management, OSF...
August 27, 2018
A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not. The investigation was conducted by a group of Australian researchers, and included a sample of 163 adults participants with an average age of roughly 58 years. Presented this week at the European Society of...
Cognoa child development assessment app for autism
August 27, 2018
In May, a pair of studies were published in the journals Autism Research and the Journal of the American Medical Informatics Association (JAMIA) that evaluated Cognoa’s artificial intelligence-based tool for early identification of autism in children. While both investigations suggest that the tool’s performance significantly exceeded those of other standardized screeners, comparing the two...
August 24, 2018
23andMe has emailed developers a warning that an API permitting use of anonymized customer datasets for third-party app development will be shut down in approximately two weeks, CNBC reports. While the raw data will remain available to clinical research partners such as GlaxoSmithKline, which invested $300 million this year to gain access to the genetic testing startup’s DNA database for drug...
August 23, 2018
Psychiatry has long stood as one of the more subjective areas of care, but new technologies and large-scale data generation and analysis may offer a more quantifiable approach to mental health treatment. In a recently published perspective, a group of Verily researchers and Former FDA Commissioner Dr. Robert Califf called for the psychiatric field to embrace digital sensors and the data sciences...
August 23, 2018
Dthera Sciences, a San Diego-based developer of clinical and consumer digital therapeutics for individuals with neurodegenerative conditions, announced today that its development stage intervention, DTHR-ALZ, has been granted Breakthrough Device designation by the FDA. As laid out in the 21st Century Cures Act, the Breakthrough Devices Program looks to streamline new medical technologies that...
Omkar Kulkarni, CIO at Children's Hospital Los Angeles

Omkar Kulkarni, CIO at Children's Hospital Los Angeles, will be speaking at the Health 2.0 Conference in Santa Clara Sept. 16.

August 23, 2018
From digital therapeutics to virtual care and artificial intelligence, there are a number of novel advancements in healthcare technology offering providers an opportunity to revamp care for the better. But talking about healthcare innovation is easy — it’s the deployment and adoption that often trips up larger healthcare providers. Omkar Kulkarni, Children’s Hospital Los Angeles’ recently...
August 22, 2018
Y Combinator’s biannual Demo Day is winding to a close after presentations from dozens of tech entrepreneurs. The Silicon Valley-based accelerator has historically had a hand in the development of numerous healthcare tech startups, and this week’s event seems to be no exception. According to TechCrunch, 28 percent of the 122 startups that presented at Demo Day fell within the healthcare vertical...
August 21, 2018
SOC Telemed (formerly Specialists on Call) announced yesterday that it has acquired behavioral health telemedicine company JSA Health, and will be adding JSA Health’s services to its acute telemedicine platform. The terms of the deal were not disclosed. “JSA achieved a strong foothold in the telepsychiatry industry, but as a single specialty practice the company sought scalability that SOC...